Volpara Health Technologies Ltd represents values of innovation, collaboration, and patient-centered care. As a leading provider of breast imaging analytics and technology, the company is dedicated to empowering healthcare providers with advanced solutions that improve early detection and treatment of breast cancer. Volpara's corporate philosophy is rooted in the belief that every woman should have access to personalized, high-quality breast care. By leveraging cutting-edge technology and a customer-centric approach, Volpara aims to reduce breast cancer mortality rates and enhance overall breast health. Volpara Health Technologies Ltd is committed to driving positive change in the healthcare industry through its values and dedication to improving patient outcomes.

Volpara Health Technologies Ltd is primarily present in countries such as the United States, Canada, Australia, New Zealand, Singapore, and the United Kingdom. These regions act as key markets for the company, where it focuses on providing advanced breast imaging analytics and solutions. Volpara's presence in these countries enables it to serve a wide range of healthcare providers and support breast cancer screening and early detection efforts globally.

Volpara Health Technologies Ltd has achieved significant milestones throughout its journey. Some notable accomplishments include expanding its global presence and customer base, launching cutting-edge products and services, and forging strategic partnerships with industry leaders. The company has consistently demonstrated its commitment to improving early detection and treatment outcomes for breast cancer, empowering healthcare providers with innovative solutions. Volpara Health Technologies Ltd has also made strides in research and development, continuously advancing its technology to enhance breast imaging and patient care. These milestones highlight the company's dedication to transforming the breast healthcare landscape and solidify its position as a leading player in the industry.

Volpara Health Technologies Ltd is a leading medical technology company specializing in breast imaging analytics and analysis software. Founded in 2009, Volpara has emerged as a key player in the field, providing innovative solutions for early detection and personalized breast cancer screening. The company's proprietary software, VolparaDensity, accurately measures breast tissue density, a significant risk factor for breast cancer. Volpara's advanced technologies enable healthcare professionals to make informed decisions about breast health, resulting in earlier diagnoses and improved patient outcomes. With a strong commitment to revolutionizing breast cancer screening, Volpara Health Technologies Ltd continues to set new standards in the industry.

The main competitors of Volpara Health Technologies Ltd in the market include Hologic Inc., GE Healthcare, and iCAD Inc.

Volpara Health Technologies Ltd primarily operates in the healthcare industry.

Volpara Health Technologies Ltd is an innovative healthcare company specializing in breast imaging analytics and software. As a leader in the field, Volpara aims to improve early detection of breast cancer through its advanced technology solutions. The company provides professional software and services that offer personalized assessments of breast density, image quality, and patient-specific risk. By empowering healthcare providers with accurate and objective data, Volpara is revolutionizing breast cancer screening and diagnosis. With its business model focused on delivering state-of-the-art solutions, Volpara Health Technologies Ltd strives to ensure better outcomes and enhanced patient care in the fight against breast cancer.

De K/W-verhouding kan momenteel niet worden berekend voor Volpara Health Technologies.

De KUV kan momenteel niet worden berekend voor Volpara Health Technologies.

De AlleAktien Qualitätsscore kan momenteel niet berekend worden voor Volpara Health Technologies.

De omzet kan momenteel niet worden berekend voor Volpara Health Technologies.

De winst kan momenteel niet berekend worden voor Volpara Health Technologies.

Volpara Health Technologies specializes in diagnostic and medical imaging solutions for breast health. The company operates in various areas including software development, data analysis, medical imaging, and health provider information. Their main products include software solutions for breast cancer diagnosis, such as VolparaDensity for breast density analysis and VolparaEnterprise for preventive breast cancer diagnosis. Volpara also offers the VolparaLive service, which provides specialized medical support for breast health through remote monitoring. The company collaborates with healthcare professionals and organizations to improve patient care and aims to reduce cancer rates through better diagnostics and screening methods. Volpara's business model includes direct sales of software and services to hospitals, healthcare facilities, and clinics, as well as a partner program for healthcare industry companies. They offer their products and services globally and continuously improve their technology to meet the needs of patients and healthcare providers.

Volpara Health Technologies keert een dividend van 0 NZD uit, verdeeld over betalingen per jaar.

De dividend kan momenteel niet worden berekend voor Volpara Health Technologies of het bedrijf keert geen dividend uit.

De ISIN van Volpara Health Technologies is NZVHTE0001S6.

Het WKN van Volpara Health Technologies is A2DVK1.

De ticker van Volpara Health Technologies is VHT.AX.

Binnen de laatste 12 maanden betaalde Volpara Health Technologies een dividend van . Dit komt overeen met een dividendrendement van ongeveer . Voor de komende 12 maanden zal Volpara Health Technologies naar verwachting een dividend van 0 NZD betalen.

De dividendrendement van Volpara Health Technologies is momenteel .

Volpara Health Technologies betaalt elk kwartaal een dividend uit. Dit wordt uitgekeerd in de maanden .

Volpara Health Technologies betaalde de afgelopen 0 jaar elk jaar dividend.

Voor de komende 12 maanden wordt een dividend van 0 NZD verwacht. Dit komt overeen met een dividendrendement van 0 %.

Volpara Health Technologies wordt toegewezen aan de sector 'Gezondheid'.

Om het laatste dividend van Volpara Health Technologies van 7-9-2024 ter hoogte van 0 NZD te ontvangen, moest je het aandeel voor de ex-datum op 7-9-2024 in je portefeuille hebben.

De laatste dividenduitkering vond plaats op 7-9-2024.

In het jaar 2023 heeft Volpara Health Technologies 0 NZD aan dividenden uitgekeerd.

De dividenden van Volpara Health Technologies worden in NZD uitgekeerd.